The Indian government has directed medical device companies to improve how they report problems linked to their products. This step aims to strengthen patient safety and ensure quicker action when issues arise.
New Reporting Rules Issued
The Indian Pharmacopoeia Commission (IPC) has instructed all companies holding marketing rights for medical devices to report adverse events promptly. They must now report both serious and non-serious incidents, whether expected or unexpected, to the Materiovigilance Programme of India (MvPI). This reporting is no longer optional but a key part of safety monitoring.
Reason Behind the Directive
Industry officials and regulators raised concerns that many device makers were underreporting incidents linked to locally manufactured equipment. As per Economic Times, this gap in reporting has slowed down efforts to identify potential risks and delayed corrective steps in the healthcare system. Moreover, a recent recall of a hip-replacement device highlighted the need for better vigilance and faster information sharing.
Benefits of Timely Reporting
Reporting adverse events quickly helps regulators and manufacturers:
- Spot new or emerging risks
- Determine how frequently known problems occur
- Implement risk mitigation measures, such as design changes, safety updates, and regulatory actions
The IPC also emphasized that the government has created multiple reporting channels to make it easier for firms to comply with these requirements.
Strengthening Patient Safety
The government mandates post-market surveillance (PMS) for all medical devices to ensure they remain safe and effective after being sold. This enhanced vigilance supports ongoing analysis of device performance and helps safeguard patients across India.